REGISTER HERE Join Bioverse webinar episode 8 to review the exciting presentations from AACR 2024 in San Diego. Our experts of cancer research and drug development will share will discuss: The industry-shaping data of ADC and radiopharmaceutical Clinical data from cell therapy, bispecific antibody, cancer vaccine, targeted therapy, and other drug classes Novel targets and industry-shaping scientific breakthroughs Practice-changing or market-moving clinical trial data Highlights of presentations from Asian biotech companies About the Speakers As LifeMine’s Chief Data Officer, Lihua brings vast experience in drug discovery from target identification to translational medicine, data science, and [...]

REGISTER HERE This panel of decorated physician scientists have brought about a dozen of drugs to the market and have collectively accumulated 70 years of industry drug development experience. The approved drugs (e.g., YEROVY, KEYTRUDA, ZEJULA, JEMPERLI, BLENREP, TZIELD, TREMFYA, ORENCIA, NULOJIX, FASENRA etc) span from immuno-oncology, precision-oncology, ADC, autoimmune diseases, diabetes, dermatology, to COVID, during their executive roles at Merck, JNJ, AstraZeneca, BMS, GSK, Sanofi, and a number of biotechs. Many of the biotechs were founded our panelists and later acquired by biopharmas. This is the ideal panel to share the “Checklists”, or best practice, behind this stellar [...]